Syntonix Pharmaceuticals
Searching for Syntonix Pharmaceuticals info? Then you have come to exactly the right place. At thebigfreezefestival.com.au we collected all data about Syntonix Pharmaceuticals: corporate office address, support phones, working hours, customer complaints, etc.
SYNTONIX
- https://syntonix.com/
- Syntonix's OncoStemCell provides a product to the drug development companies to significantly reduce the time taken to screen possible drug candidates for cancer. …
Syntonix Pharmaceuticals - Crunchbase Company …
- https://www.crunchbase.com/organization/syntonix-pharmaceuticals
- Contact Email [email protected]. Phone Number (781)547-6000. Syntonix discovers and develops novel, long-acting, proprietary therapeutic products using the company’s …
Syntonix Pharmaceuticals, Inc. - Waltham, USA
- https://www.bionity.com/en/companies/16591/syntonix-pharmaceuticals-inc.html
- Syntonix discovers and develops novel, long-acting, proprietary therapeutic products using the company’s proprietary Fc-fusion proteins and other engineered ligands which bind to …
Syntonix Pharmaceuticals, Inc. And Boehringer Ingelheim …
- https://www.biospace.com/article/releases/syntonix-pharmaceuticals-inc-and-boehringer-ingelheim-corporation-enter-collaboration-for-up-to-63-million-to-optimize-therapeutic-/
- Syntonix' SynFusion drugs link the Fc region of an antibody to a drug in a novel manner, providing longer-acting therapeutic proteins or peptides that are injected …
Syntonix Pharmaceuticals - Headquarters Locations, …
- https://www.cbinsights.com/company/syntonix-pharmaceuticals
- About Syntonix Pharmaceuticals Syntonix specializes in the discovery and development of therapeutic proteins for treatment of chronic diseases such as hemophilia, anemia, …
Syntonix Pharmaceuticals | LinkedIn
- https://www.linkedin.com/company/syntonix-pharmaceuticals
- Syntonix Pharmaceuticals Biotechnology Research Follow About us Industries Biotechnology Research Company size 11-50 employees Type Privately Held Locations …
Syntimmune Turns Drug For Rare Anemia Into $400M …
- https://xconomy.com/boston/2018/09/26/syntimmune-turns-drug-for-rare-anemia-into-400m-alexion-buyout/
- Syntimmune, a biotech startup formed by the veteran founders of the hemophilia drug developer Syntonix, has been acquired by Alexion Pharmaceuticals for …
Syntonix Pharmaceuticals | Better Business Bureau® …
- https://www.bbb.org/us/ma/waltham/profile/pharmaceutical-manufacturing/syntonix-pharmaceuticals-0021-8315
- 26 Business Started: 1/1/1997 Type of Entity: Corporation Number of Employees: 1 Business Management Mr. Garen Bohlin, President Contact Information Principal Mr. Garen …
Biovitrum and Syntonix Dose First Hemophilia B Patient in
- https://www.globenewswire.com/news-release/2008/05/27/50207/0/en/Biovitrum-and-Syntonix-Dose-First-Hemophilia-B-Patient-in-Clinical-Trial-of-a-Novel-Factor-IXFc-Treatment.html
- About Syntonix Syntonix Pharmaceuticals, Inc. (Waltham, MA, USA) is a wholly-owned subsidiary of Biogen Idec. Syntonix is developing next generation …
Biogen Acquires Syntonix Pharmaceuticals | Mergr M&A …
- https://mergr.com/biogen-acquires-syntonix-pharmaceuticals
- Syntonix Pharmaceuticals, Inc. is a needle-free drug delivery company utilizing the FcRn receptor to transport macromolecules across epithelial barriers in the …
Found Syntonix Pharmaceuticals information?
The links above have surely given you a comprehensive answer to all questions about Syntonix Pharmaceuticals.
If you are interested in any other information about business companies, choose the appropriate page.